Evidence map›Paper›PMID 26939581›Full record

ArticleGenome medicine2016

Genome dynamics of multidrug-resistant Acinetobacter baumannii during infection and treatment.

Meredith S Wright, Alina Iovleva, Michael R Jacobs, Robert A Bonomo, Mark D Adams

Open access · goldAbstract read
In one paragraph

Article in Genome medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 71 citations in OpenAlex.

  1. Phage-antibiotic synergy attenuatesFrontiers in cellular and infection microbiology · 2026
    Article
  2. Article
  3. Phenotypic and genetic heterogeneity ofMicrobial genomics · 2025
    Article
  4. Article
  5. Article
  6. PNAS nexus · 2023
    Article
  7. Article
  8. Frontiers in microbiology · 2023
    Review
  9. Article
  10. Bacterial Community and Genomic Analysis of Carbapenem-ResistantPharmaceuticals (Basel, Switzerland) · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Evolution ofInfection and drug resistance · 2021
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Meredith S WrightThe J. Craig Venter Institute, La Jolla, CA, USA.
Alina IovlevaDepartment of Medicine, University Hospitals Case Medical Center, Cleveland, OH, USA.
Michael R JacobsDepartment of Pathology, University Hospitals Case Medical Center, Cleveland, OH, USA.
Robert A BonomoDepartments of Pharmacology, Molecular Biology and Microbiology, and the Center for Proteomics, Case Western Reserve University, Cleveland, OH, USA.
Mark D AdamsThe J. Craig Venter Institute, La Jolla, CA, USA. madams@jcvi.org.
J. Craig Venter Institute · USUniversity Hospitals Case Medical Center · USCase Western Reserve University · US

Funding

Antibacterial Resistance Leadership Group (ARLG)UM1AI104681 · NIAID · DUKE UNIVERSITY · PI Vance G. Fowler, Henry F HENRY CHAMBERS · 2013 to 2026
$180.8M
The J. Craig Venter Institute Genome Center for Infectious DiseasesU19AI110819 · NIAID · J. CRAIG VENTER INSTITUTE, INC. · PI TAN, GENE · 2014 to 2018
$29.7M
Understanding B-Lactam Resistance in Acinetobacter baumanniiR01AI072219 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI ROBERT A. BONOMO, Philip N. Rather · 2007 to 2026
$6.6M
Understanding ceftazidime resistance in SHV B-LactamasesR01AI063517 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI BONOMO, ROBERT A. · 2005 to 2023
$4.9M
A Mechanism-Based Approach to Metallo-beta-Lactamase InhibitionR01AI100560 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI BONOMO, ROBERT A., SPENCER, JAMES · 2012 to 2022
$4.4M
Evolution of multidrug resistance in Acinetobacter baumanniiR01GM094403 · NIGMS · J. CRAIG VENTER INSTITUTE, INC. · PI ADAMS, MARK D · 2011 to 2014
$1.3M
Molecular Epidemiology of Carbapenem-Resistant Klebsiella pneumoniaeR21AI114508 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI BONOMO, ROBERT A., VAN DUIN, DAVID · 2015 to 2016
$445k
The Continuing Challenge of Carbapenemases in K. pneumoniae: KPC-2 & NDM-1I01BX001974 · VA · LOUIS STOKES CLEVELAND VA MEDICAL CENTER · PI BONOMO, ROBERT A. · 2013 to 2024
–
BLRD VA I01 BX001974NIAID NIH HHS R01 AI063517NIAID NIH HHS R01AI063517NIAID NIH HHS R01 AI072219NIAID NIH HHS R01AI072219NIAID NIH HHS R01 AI100560NIAID NIH HHS R01AI100560NIAID NIH HHS R21 AI114508NIAID NIH HHS U19 AI110819NIAID NIH HHS UM1 AI104681NIAID NIH HHS UM1AI104681NIGMS NIH HHS R01 GM094403NIGMS NIH HHS R01GM094403
6 · The paper itself

Abstract

backgroundLimited treatment options are available for patients infected with multidrug (MDR)- or pan-drug (PDR)-resistant bacterial pathogens, resulting in infections that can persist for weeks or months. In order to better understand transmission and evolutionary dynamics of MDR Acinetobacter baumannii (Ab) during long-term infection, we analyzed genomes from a series of isolates from individual patients at isolate-specific, patient-specific, and population levels.

methodsWhole genome analysis of longitudinal isolates (range 2-10 isolates per patient spanning 0-829 days) from 40 patients included detection of single-nucleotide variants (SNVs), insertion sequence (IS) mapping, and gene content changes.

resultsPhylogenetic analysis revealed that a significant fraction of apparently persistent infections are in fact due to re-infection with new strains. SNVs primarily resulted in protein coding changes, and IS events primarily interrupted genes or were in an orientation such that the adjacent gene would be over-expressed. Mutations acquired during infection were over-represented in transcriptional regulators, notably pmrAB and adeRS, which can mediate resistance to the last line therapies colistin and tigecycline, respectively, as well as transporters, surface structures, and iron acquisition genes.

conclusionsMost SNVs and IS events were isolate-specific indicating these mutations did not become fixed on the time scale investigated, yet over-representation of independent mutations in some genes or functional categories suggests that they are under selective pressure. Genome analysis at the population-level suggests that gene transfer including recombination also contributes to Ab evolutionary dynamics. These findings provide important insight into the transmission dynamics of Ab and the identification of patients with repeat infections has implications for infection control programs targeted to this pathogen.

Indexed as

Genome, BacterialGenomicsAcinetobacter baumanniiAcinetobacter InfectionsAnti-Bacterial AgentsComputational BiologyDrug Resistance, Multiple, BacterialGenes, BacterialGenetic VariationHigh-Throughput Nucleotide SequencingHumansMutagenesis, InsertionalPhylogenyPolymorphism, Single NucleotideAnti-Bacterial Agents

Identifiers

PMID26939581
PMCPMC4776386
OpenAlexW2291948557

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.